Erasca (ERAS) Non Operating Income (2020 - 2026)

Erasca (ERAS) reported Non Operating Income of $4.5 million for Q1 2026, up 5982.89% on a YoY basis from $73501.2 in Q1 2025, and down 72.99% quarter-over-quarter from $16.6 million in Q4 2025.

Erasca (ERAS) Non Operating Income (2020 - 2026) Analysis & Trends

Erasca has reported Non Operating Income for 7 years, with the latest figure at $4.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Income rose 5982.89% year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at $29.2 million (up 27.16% YoY), and the FY2025 full-year result was $16.4 million, down 8.8% from the prior year.
  • Non Operating Income for Q1 2026 stood at $4.5 million, down from $16.6 million in the prior quarter.
  • The five-year high for Non Operating Income was $18.3 million in Q4 2024, with the low at -$76000.0 in Q1 2025.
  • Historically, Non Operating Income has averaged $4.5 million across 5 years, with a median of $3.9 million in 2025.
  • Annual changes were most pronounced in 2023 — Non Operating Income jumped 8040.43% — and 2025, when it plunged 101.98%.
  • Erasca's Non Operating Income stood at $2.8 million in 2022, then surged by 47.49% to $4.2 million in 2023, then surged by 338.5% to $18.3 million in 2024, then decreased by 9.5% to $16.6 million in 2025, then plunged by 72.99% to $4.5 million in 2026.
  • The last three Non Operating Income figures came in at $4.5 million (Q1 2026), $16.6 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 444,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 9.35 Mn
10 Erasca 4.16 Bn 3.92 Bn - 4.47 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.47 Mn
Dec 31, 2025 16.55 Mn
Sep 30, 2025 3.93 Mn
Jun 30, 2025 4.25 Mn
Mar 31, 2025 -76,000.00
Dec 31, 2024 18.29 Mn
Sep 30, 2024 173,000.00
Jun 30, 2024 4.58 Mn
Mar 31, 2024 3.83 Mn
Dec 31, 2023 4.17 Mn
Sep 30, 2023 4.30 Mn
Jun 30, 2023 4.19 Mn
Mar 31, 2023 3.83 Mn
Dec 31, 2022 2.83 Mn
Sep 30, 2022 1.47 Mn
Jun 30, 2022 297,000.00
Mar 31, 2022 47,000.00
Dec 31, 2021 584,000.00
Sep 30, 2021 -25,000.00
Jun 30, 2021 -30,000.00